Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05730244 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 19, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 11 more changesShow less
    • Enrollment target: 60 to 20
    • Primary completion date: Dec 31, 2023 to Jan 31, 2026
    • Start date changed from estimate of Feb 15, 2023 to Mar 1, 2025
    • Study completion date: Jun 30, 2024 to Dec 30, 2026
    • Interventions: Cassia alata extract (Drug), Placebo (Drug) to 20% Cassia alata cream (Drug)
    • Eligibility criteria shortened, about 9 words
    • Secondary endpoints: 3 to 1
    • Study description expanded, about 8 words
    • Site details revised
    • Study title revised
    • Study arms: 2 to 1
  2. Eligibility criteria shortened, about 46 words
    • Study title shortened, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to establish the efficacy of Cassia alata extract as a cream form in treating tinea versicolor (liver spots/shifting clouds). The main questions the study aims to answer are:• Does the use of this extract help resolve tinea versicolor better than no treatment? Does the use of this cream have significant side effects i.e, is it safe? Participants will be asked to treat a designated area while leaving additional areas untreated. 1-2 finger tip units of cream will be applied to the treatment site twice daily at least 8 hours apart. Participants will attend the trial clinic every 4 weeks for 12 weeks.
Trial Details
NCT Number NCT05730244
Lead Sponsor The University of The West Indies
Conditions
(from sponsor)		 Tinea Versicolor, Pityriasis Versicolor
Related terms Tinea Versicolor
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov